Upregulation of the proinflammatory cytokine-induced neutrophil chemoattractant-1 and monocyte chemoattractant protein-1 in rats' intestinal anastomotic wound healing—Does it matter?  by Alzoghaibi, Mohammed A. & Zubaidi, Ahmed M.
Asian Journal of Surgery (2014) 37, 86e92Available online at www.sciencedirect.com
ScienceDirect
journal homepage: www.e-asianjournalsurgery.comORIGINAL ARTICLEUpregulation of the proinflammatory
cytokine-induced neutrophil
chemoattractant-1 and monocyte
chemoattractant protein-1 in rats’ intestinal
anastomotic wound healingdDoes it matter?Mohammed A. Alzoghaibi a,b,*, Ahmed M. Zubaidi caCenter of Excellence in Biotechnology Research, King Saud University, Riyadh, Saudi Arabia
bDepartment of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia
cDepartment of Surgery, College of Medicine, King Saud University, Riyadh, Saudi ArabiaReceived 22 January 2013; received in revised form 13 July 2013; accepted 23 July 2013
Available online 21 September 2013KEYWORDS
CINC-1;
intestinal
anastomosis;
MCP-1;
TGF-b;
woundConflicts of interest: The authors d
or materials discussed in the manuscr
* Corresponding author. Departmen
Arabia.
E-mail address: zzoghaibi@gmail.c
1015-9584/$36 Copyright ª 2013, Asia
http://dx.doi.org/10.1016/j.asjsur.20Summary Background: The proinflammatory cytokines and growth-promoting factor are
essential components of the wound healing process. We hypothesized that under healthy con-
ditions, faster healing of intestinal anastomotic wound is due to an early upregulation of proin-
flammatory cytokines, cytokine-induced neutrophil chemoattractant-1 (CINC-1) that is
followed by a quicker upregulation of homeostatic chemokine, monocyte chemoattractant
protein-1 (MCP-1) and late upregulation of transforming growth factor (TGF-b).
Methods: We characterized the time course of CINC-1, MCP-1 and TGF-b release at four
wounds (skin, muscle, small bowel, and colonic anastomosis) after surgery on 38 juvenile male
Sprague Dawley rats. The tissue samples of each site were harvested at 0 (control), 1, 3, 5, 7
and 14 days postoperatively (nZ 6e8/group) and analyzed by ELISA kits for CINC-1, MCP-1 and
TGF-b.
Results: CINC-1 expression peaked earlier in muscle and colonic wounds when compared to skin
and small bowel. MCP-1 levels were elevated early in skin and muscle wounds, but later expres-
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CINC-1, MCP-1 in rats’ intestinal wounds 87Conclusion: An earlier peak in CINC-1 levels and later expression of MCP-1 were seen in colonic
wounds, but no significant increase in TGF-b levels was observed. These findings support the
early healing process in intestinal anastomotic wounds.
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reserved.1. Introduction
The most common complication following colorectal sur-
gery is anastomotic leakage, which is associated with a high
mortality rate.1,2 Wound healing is a complex procedure
that requires a highly regulated series of events, including
interactions between many cell types, production of
different soluble factors, and growth of matrix compo-
nents. Normal wound healing has four phasesdhemostasis,
inflammation, tissue formation, and tissue remodeling.3
The primary goal of wound repair is to achieve hemosta-
sis, which represents the first step in wound healing.
The inflammatory phase begins after 6 hours of tissue
injury. This phase is associated with some important events,
such as migration of activated neutrophils, macrophages,
and lymphocytes from the circulation into the injured tissue.
Neutrophils are the first leukocytes to infiltrate the injured
tissue, followed by monocytes.4 Engelhardt et al5 reported
that neutrophil infiltration into a human skin wound is
extremely high during the initial days, reaching a maximum
level on Day 1. Neutrophils are dominant in the wound site
during the initial days. By contrast, macrophages (activated
monocytes) reached their maximum level on Day 2. Che-
mokines selectively mediate the recruitment of neutrophils
and monocytes in the affected area. Interleukin-8 (IL-8)
mRNA expression in the wound site is maximum on Day 1,6
and then it declines to reach its lowest level on Day 4.
Another neutrophil chemokine, growth-regulated oncogene
(GRO-a), is also expressed within 4 days after wounding.
There is a strong correlation between the levels of IL-8, GRO-
a, and neutrophil infiltration. The cooperative expression of
IL-8 and GRO-a in the wound site enhances neutrophil
migration to this site because each of them stimulates neu-
trophils via different receptors. Importantly, rats lack a ho-
molog of human IL-8, but they express a cytokine with similar
properties and as potent a chemoattractant as IL-8, named
cytokine-induced neutrophil chemoattractant (CINC-1).7e9
Monocytes infiltrate the injured tissue in response to
chemotactic cytokines such as monocyte chemoattractant
protein-1 (MCP-1). MCP-1 is released from basal keratino-
cytes adjacent to the epidermis or from endothelial cells.6
Peak levels of MCP-1 are detected 1e2 days after skin
wounding and slowly decline thereafter to Day 7.5 Trans-
forming growth factor-a (TGF-a) is another important cyto-
kine for extracellular matrix synthesis and remodeling, which
is released by monocytes and macrophages. These growth
factors and cytokines function to promote the last two
phases of healing: tissue formation and tissue remodeling.10
Thus, an alteration of the expression or function of inflam-
matory cytokines may lead to the persistence of an inflam-
matory phase and alter the normal wound healing process.
Therefore, successful acute wound healing occurs whenproinflammatory cytokines, such as CINC-1, control the re-
cruitment of neutrophils in inflammatory and tissue injury
phases, and homeostatic chemokines, such as MCP-1, fulfill
the housekeeping functions in cleaning thewound from debris
during the hemostasis phase.11
Based on these observations, we hypothesized that under
healthy conditions, faster healing of intestinal anastomotic
wound in comparison to skin and muscle incisional wound is
due to early upregulation of proinflammatory cytokine (CINC-
1), followed by quicker upregulation of homeostatic che-
mokine (MCP-1) and late upregulation of TGF-b. To the best
of our knowledge, this is the first study to investigate tem-
poral expressions of CINC-1 and MCP-1 at four different tis-
sues in rats: skin, muscle, small intestine, and colon.
2. Materials and methods
2.1. Animals
Thirty-eight male SpragueeDawley rats (200e250 g) (ani-
mals were obtained from animal house of College of Medi-
cine, King Saud University) were used for the study. Each rat
was housed individually in a single cage and placed in a room
with controlled temperature and light/dark cycle (12 h/
12 h). The animals were allowed ad libitum intake of normal
rat pellet. Thirty-eight animals, divided into groups with six
rats in each group, underwent surgery; enzyme-linked
immunosorbent assay (ELISA) was performed for CINC-1,
MCP-1, and TGF-b at the following time points: 0 (control),
Day 1, Day 3, Day 5, Day 7, and Day 14. Studies were con-
ducted according to a protocol approved by the Animal Care
Committee of the College of Medicine, King Saud University,
Riyadh, Saudi Arabia.
2.2. Surgical procedure
The animals were anesthetized with 1e2% inhalational
halothane. A single preoperative prophylactic dose of cefa-
zolin (30 mg/kg; Novopharm Limited, Toronto, Ontario,
Canada) was administered subcutaneously. The abdomen
was prepared, shaved, and entered through a midline inci-
sion. Transection with immediate reanastomosis was per-
formed both at the terminal ileum (10 cm proximal to the
ileocecal valve) and at the transverse colon (1 cmproximal to
the splenic flexure). The techniques were similar to previ-
ously published methods.12,13 A standardized end-to-end
anastomosis was performed with 8e10 interrupted invert-
ing sutures using 6-0 monofilament polypropylene (Prolene
TM; Ethicon, Parsippany, NJ, USA). Polypropylene was cho-
sen because of its inert characteristics, minimizing the in-
flammatory reaction associated with resorption of an
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sterile normal saline and closed in layers using interrupted
sutures of 4-0 polypropylene in the fascia and skin.
After the procedure, rats were housed in single cages.
The animals were allowed water immediately and solid
food at 24 hours postsurgery (20 g/d). Daily oral intake and
weight were recorded. At the time of sacrifice, rats were
anesthetized with halothane/oxygen using a nose cone.
Midline cutaneous and fascial wounds were harvested for
5 mm on each side of the wound, dissecting the skin and
fascia away from the underlying tissue, followed by an en
bloc excision without disturbing the actual wound. A lapa-
rotomy was then performed. Both the small bowel and the
colonic anastomoses were identified and dissected away
gently from the surrounding tissues. Care was taken to
avoid disrupting adhesions as much as possible. If the
anastomosis was not intact, the animal was excluded from
further study. A 5 mm segment from each side of each
anastomosis was excised en bloc. The rats were then killed
by an intracardiac injection of 50 mg/kg sodium pento-
barbital. All harvested tissues were wrapped in an
aluminum foil and frozen immediately in a liquid nitrogen
bath. All frozen tissue samples were kept at 80C until
further processing for cytokine measurement.2.3. Extraction of tissue proteins
Tissues were processed according to the method reported
by Zubaidi et al13 and Takahashi and Das14 with some
modification. In brief, each tissue specimen was thawed,
minced into 2 mm cubes, washed five times in 5 vol. of
phosphate buffered saline (PBS), pH 7.2, containing 2 mM
phenylmethylsulfonyl fluoride and 2 mM sodium azide.
After centrifugation at 1000 g for 5 minutes, the tissue
pellet was homogenized in the same buffer including 1 mM
EDTA [5 vol. (wt/vol.)] on ice in a Polytron (Kinematic PT,
Dispersing and Mixing Technology; Lucerne, Switzerland) at
5e10 speed for four 10-second intervals. Homogenates
were centrifuged at 2000 g for 20 minutes to remove large
tissue particles and recentrifuged at 13,200 g for 90 mi-
nutes to obtain a clear supernatant. Supernatants of each
tissue specimen were further divided in 200 mL aliquots,
labeled, and stored at 70C. Prior to each experiment, the
extracts were thawed and centrifuged at 13,200g for 5
minutes to remove debris.2.4. ELISA assays
The supernatants were assayed quantitatively for CINC-1,
MCP-1, and TGF-b (Assay Design, Ann Arbor, MI, USA), using
a 96-well microtiter plate reader. The respective cytokine
levels of the different tissue samples were determined by
the means of duplicated measurements requiring
50e200 mL of extract. Results were verified using the in-
ternal controls supplied with each kit, with a known con-
centration of the target protein. Optical density
measurements were then verified against a standardized
curve. The results were averaged at the end of the exper-
iment and expressed in pg/g wet tissue weight.2.5. Statistical analysis
Results of cytokine and growth factor measurements for all
tissues were plotted on graphs against the time of sacri-
fice. One-way analysis of variance (ANOVA) was used to
compare each cytokines or growth factors in the four
different wound sites at the same time point. ANOVA
repeated measures were used to compare the temporal
expression of each factor in a specific wound over the
period of the study. Post hoc testing was performed using
the Bonferroni and Dunnett T3 for multiple comparison,
with p < 0.05 being considered significant; SPSS version 19
(SPSS Inc., Chicago, IL, USA) was used to perform the
analysis. Results were expressed as mean  standard error
of mean.3. Results
All animals in this study were healthy, eating equivalent
amounts of chow, and gaining weight over the study period.
No visual evidence of dehiscence (abscess, fistula formation,
or fecal contamination within the peritoneum) was reported
at the time of the harvest in any of the animals. Detection of
CINC-1, MCP-1, and TGF-b expressions using the ELISA tech-
nique was investigated at the selected time points (0, Day 1,
Day 3, Day 5, Day 7, and Day 14). Results of the quantitative
analyses differed considerably between the different wound
samples and are reported separately for each wound tissue
(skin, muscle, small bowel, and colon).
Initially, CINC-1 levels of skin and small bowel wound
sites showed similar patterns of expression at all selected
time points, except for the control that showed a signifi-
cantly lower level (Fig. 1). On Day 1 postwounding, muscle
CINC-1 levels increased dramatically compared to other
selected time points but was significantly different from
that on Day 14 (291.1  107.7 pg/g wt vs. 69.5  34.8 pg/g
wt, respectively; p < 0.05; Fig. 1). By contrast, colon CINC-
1 levels tended to be higher on Day 5 than on other time
points but were not statistically significant except on Day
14, which showed significantly lower (p < 0.05) expression
than that on Day 5 (Fig. 1).
MCP-1 showed a distinct expression pattern in the small
bowel and colon wound sites in comparison to the other
wound sites. In these two wound sites, the expression of
MCP-1 showed the normal expected distribution, i.e., a
bell-shaped curve, throughout these time points (Fig. 2).
For the small bowel wounds, MCP-1 levels were significantly
higher on Day 5 in comparison to that on Day 1
(189.5  70.9 pg/g wt vs. 75.7  61.9 pg/g wt, respectively;
p < 0.05). MCP-1 expression showed a similar pattern in
colon wounds to that in the small bowel wounds; there was
no significant difference in these MCP-1 expressions
(Fig. 2). By contrast, MCP-1 expression in skin and muscle
wounds was completely opposite to that in small bowel and
colon wounds, where it showed the highest level on Day 1
among all time points. Particularly in muscle wounds, MCP-
1 expression was significantly higher on Day 1 and Day 3
than at other time points (p < 0.05; Fig. 2).
Fig. 3 showsTGF-bexpressions in all different tissues at all
the time points. In contrast to what has been shown in a
previous study,13 the prohealing TGF-b showed a significant
Figure 1 CINC-1: time course of expression. CINC-1 profile in different wound sites over time. CINC-1 levels from wound tissues
were assessed using ELISA and are expressed as pg CINC-1/g wet tissue. Data: mean  SEM, nZ 6e8 for each wound site, at each
time point. Statistical comparison over time by ANOVA (p < 0.05). ANOVA Z analysis of variance; CINC Z cytokine-induced
neutrophil chemoattractant; ELISA Z enzyme-linked immunosorbent assay; SEM Z standard error of the mean.
Figure 2 MCP-1: time course of expression. MCP-1 profile in different wound sites over time. MCP-1 levels from wound tissues
were assessed using ELISA and are expressed as pg MCP-1/g wet tissue. Data: mean  SEM, nZ 6e8 for each wound site, at each
time point. Statistical comparison over time by ANOVA (p < 0.05). ANOVA Z analysis of variance; ELISA Z enzyme-linked
immunosorbent assay; MCP Z monocyte chemoattractant protein; SEM Z standard error of the mean.
CINC-1, MCP-1 in rats’ intestinal wounds 89
Figure 3 TGF-b: time course of expression. TGF-b profile in different wound sites over time. TGF-b levels from wound tissues
were assessed using ELISA and are expressed as pg TGF-b/g wet tissue. Data: mean  SEM, n Z 6e8 for each wound site, at each
time point. Statistical comparison over time by ANOVA (p < 0.05). ANOVA Z analysis of variance; ELISA Z enzyme-linked
immunosorbent assay; SEM Z standard error of the mean; TGF Z transforming growth factor.
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b levels showed no significant change in other wound sites.
4. Discussion
Recruitment of inflammatory cells, neutrophils, and mono-
cytes/macrophages to the wound sites for sterilization and
production of growth factors is an essential process for
wound healing.5,15 The dynamics and roles of proin-
flammatory mediators, such as cytokines and chemokines, in
several types of injured and postburn tissues have recently
attracted the attention of researchers.16,17 Persistent
inflammation in gastric injuries and ulcer recurrence was
attributed to the overexpression of proinflammatory cyto-
kines, such as IL-1b and tumor necrosis factor (TNF-a), which
have many biological effects on chemokine production and
neutrophil activation.18e20 Several studies have shown that
healing of intestinal wounds is faster than skin wounds,21,22
which is attributed to the difference in the expression of
cytokines and growth factors between these two wound
sites.13 The aim of this study was to assess the cytokine
profile in postwounded skin, muscle, small bowel, and colon
in a rat model that can be used for the characterization of
alterations in proinflammatory chemokines expression pat-
terns at different time pointsd0, Day 1, Day 3, Day 5, Day 7,
and Day 14.
Chemokines are low-molecular-weight (8e10 kd)
chemotactic cytokines. They represent the chemotactic
signals that are produced by different cell types to initiate
leukocyte infiltration into inflamed or injured tissues. They
perform these functions by stimulating and increasing theexpression of adhesion molecules. Chemokines are divided
into four families, according to the position of cysteine
residues in these proteins: C, CC, CXC, and CX3C families.
Two of them have extensively been characterized as the
two largest chemokine families: a and b chemokines, cor-
responding to CXC and CC families, respectively.23 Among
many chemoattractants, CINCs are known to have a potent
chemotactic activity for neutrophils and the predominant
chemokines in rats.24 CINCs share the greatest sequence
homology with the human CXC chemokine GRO-a, which is a
neutrophil chemotactic cytokine.25
As summarized in Fig. 1, our results showed that the
levels of proinflammatory chemokine, CINC-1, were
elevated significantly up to Day 3 in wounded muscle tissues
and up to Day 5 in colonic wounds, as compared to other
time points. These results of neutrophil chemokines may
reflect the normal early expression in these two particular
wound sites, as demonstrated previously,5 but it is not the
same in the case of skin and small bowel wounds. These
results may support the faster healing process in colonic
wounds in comparison with skin wounds, as demonstrated
previously,21,22 which has been attributed to the differ-
ences in the time course, and degree of cytokine and
growth factor expressions.26 Similarly, Loram et al27 have
shown that concentrations of proinflammatory cytokines
(IL-1b, TNF-a, IL-6, and CINC-1) remained elevated for 4e8
days after surgery of skin in rats. They concluded that the
expression of these cytokines is not essential for the initial
development of postoperative primary hyperalgesia.
Neutrophils are dominant in the wound site during the
first days after surgery.4 By contrast, macrophages (activated
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a member of b-chemokines, which plays a pivotal role in the
recruitment of effector monocytes into the inflamed tis-
sues,23 MCP-1 can be produced by a variety of cell types,
including endothelial cells, epithelial cells, smooth muscle
cells, fibroblasts, and monocytes.28 Mazzucchelli et al29
found an increase in the number of MCP-1-expressing cells
in the inflamed intestinal mucosa of patients with inflam-
matory bowel diseases. Increased MCP-1 mRNA and protein
content in inflamed colonic mucosa were also reported.30,31
Another study showed that mucosal smooth muscle and
endothelial cells in the inflamed intestine of inflammatory
bowel disease patients express MCP-1.32 Other researchers
have observed that MCP-1 production was significantly lower
in the inflamed intestinal smooth muscle cells than in normal
cells.33 Gauglitz et al16 demonstrated that plasma MCP-1
levels were elevated at 24e48 hours and started to
decrease 6 days postburn injury. In our present study,
expression profiles of MCP-1 in the four wound sites were not
similar. On the one hand, MCP-1 was observed to be elevated
on Day 1 and Day 3 in skin and muscle tissues and then
declined throughout the length of the study. On the other
hand, it showed a considerable lag prior to displaying a sig-
nificant increase on Day 5 for colonic wounds. A similar result
was observed for this chemokine in small bowel wounds,
where it increased on Day 5 and remained elevated
throughout the length of the study. In this study, MCP-1
levels in small bowel and colon were observed to follow a
kinetic profile similar to that of human skin.5
TGF-b is released by several types of cells such as neu-
trophils, macrophages, fibroblasts, and keratinocytes.10
TGF-b is involved in all phases of wound healing, where it
inhibits the inflammatory process and induces fibroblast
proliferation to form the granulation tissue, deposition of
extra cellular matrix proteins, and angiogenesis.34,35
Although in a previous study, the authors failed to show
an increase in TGF-b levels for certain reasons,13 our study
showed a significant increase in TGF-b levels in the small
bowel wounds on Day 5, which may be consistent with the
findings of Buckmire et al.36 This will interpret the early
healing events in intestinal wounds in comparison to skin
wounds.21,26
In conclusion, the present study has shown an early
expression of CINC-1 and a late expression of MCP-1 in
colonic wounds, but no significant increase in TGF-b levels
was observed. Further studies should seek additional infor-
mation on the kinetics of changes in chemokine and cytokine
levels postsurgery, and the association (or lack thereof) of
changes in chemokine and cytokine levels with some other
physiological parameters such as prostaglandins, oxidant
stress, and antioxidant enzymes. We hope that this present
study provides a very good starting point for more in-detail
observations by other investigators, to improve the under-
standing of the biology of wound healing as a guide for the
development and use of cytokine/anticytokine and growth
factor therapies in the preoperative period.Acknowledgments
This work was supported by King Abdulaziz City for Science
and Technology (KACST) grant number: ARP-28-82. Wewould like to thank Mr. Sabirin S. for his help in running the
samples.
References
1. Dubay DA, Franz MG. Acute wound healing: the biology of
acute wound failure. Surg Clin North Am. 2003;83:463e481.
2. Pronio A, Di Filippo A, Narilli P, et al. [Anastomotic dehiscence
in colorectal surgery. Analysis of 1290 patients]. Chir Ital.
2007;59:599e609 [Article in Italian].
3. Nwomeh BC, Yager DR, Cohen IK. Physiology of the chronic
wound. Clin Plast Surg. 1998;25:341e356.
4. Clark RA, Henson PM. Overview and General Considerations of
Wound Repair. The Molecular and Cellular Biology of Wound
Repair. New York: Plenum Press; 1988.
5. Engelhardt E, Toksoy A, Goebeler M, et al. Chemokines IL-8,
GROalpha, MCP-1, IP-10, and Mig are sequentially and differ-
entially expressed during phase-specific infiltration of leuko-
cyte subsets in human wound healing. Am J Pathol. 1998;153:
1849e1860.
6. Gillitzer R, Goebeler M. Chemokines in cutaneous wound
healing. J Leukoc Biol. 2001;69:513e521.
7. Cugini D, Azzollini N, Gagliardini E, et al. Inhibition of the che-
mokine receptor CXCR2 prevents kidney graft function deteriora-
tiondue to ischemia/reperfusion.Kidney Int. 2005;67:1753e1761.
8. Nakagawa H, Ikesue A, Kato H, et al. Changes in the levels of
rat interleukin 8/CINC and gelatinase in the exudate of
carrageenin-induced inflammation in rats. J Pharmacobiodyn.
1992;15:461e466.
9. Ramos CD, Heluy-Neto NE, Ribeiro RA, Ferreira SH, Cunha FQ.
Neutrophil migration induced by IL-8-activated mast cells is
mediated by CINC-1. Cytokine. 2003;21:214e223.
10. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med.
1999;341:738e746.
11. Wagner W, Wehrmann M. Differential cytokine activity and
morphology during wound healing in the neonatal and adult rat
skin. J Cell Mol Med. 2007;11:1342e1351.
12. Attard JA, Raval MJ, Martin GR, et al. The effects of systemic
hypoxia on colon anastomotic healing: an animal model. Dis
Colon Rectum. 2005;48:1460e1470.
13. Zubaidi A, Buie WD, Hart DA, Sigalet D. Temporal expression of
cytokines in rat cutaneous, fascial, and intestinal wounds: a
comparative study. Dig Dis Sci. 2010;55:1581e1588.
14. Takahashi F, Das KM. Isolation and characterization of a colonic
autoantigen specifically recognized by colon tissue-bound
immunoglobulin G from idiopathic ulcerative colitis. J Clin
Invest. 1985;76:311e318.
15. Martin P. Wound healingdaiming for perfect skin regeneration.
Science. 1997;276:75e81.
16. Gauglitz GG, Song J, Herndon DN, et al. Characterization of the
inflammatory response during acute and post-acute phases
after severe burn. Shock. 2008;30:503e507.
17. Hamaguchi M, Watanabe T, Higuchi K, et al. Mechanisms and
roles of neutrophil infiltration in stress-induced gastric injury
in rats. Dig Dis Sci. 2001;46:2708e2715.
18. Le J, Vilcek J. Tumor necrosis factor and interleukin 1: cyto-
kines with multiple overlapping biological activities. Lab
Invest. 1987;56:234e248.
19. Pober JS, Gimbrone Jr MA, Lapierre LA, et al. Overlapping
patterns of activation of human endothelial cells by interleukin
1, tumor necrosis factor, and immune interferon. J Immunol.
1986;137:1893e1896.
20. Pober JS, Bevilacqua MP, Mendrick DL, et al. Two distinct
monokines, interleukin 1 and tumor necrosis factor, each
independently induce biosynthesis and transient expression of
the same antigen on the surface of cultured human vascular
endothelial cells. J Immunol. 1986;136:1680e1687.
92 M.A. Alzoghaibi, A.M. Zubaidi21. Brasken P. Healing of experimental colon anastomosis. Eur J
Surg Suppl. 1991;566:1e51.
22. Jiborn H, Ahonen J, Zederfeldt B. Healing of experimental
colonic anastomoses. III. Collagen metabolism in the colon
after left colon resection. Am J Surg. 1980;139:398e405.
23. Luster AD. Chemokinesdchemotactic cytokines that mediate
inflammation. N Engl J Med. 1998;338:436e445.
24. Shibata F, Konishi K, Kato H, et al. Recombinant production
and biological properties of rat cytokine-induced neutrophil
chemoattractants, GRO/CINC-2 alpha, CINC-2 beta and CINC-3.
Eur J Biochem. 1995;231:306e311.
25. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K.
Properties of the novel proinflammatory supergene "inter-
crine" cytokine family. Annu Rev Immunol. 1991;9:617e648.
26. Schaffer M, Fuchs N, Volker J, et al. Differential effect of
tacrolimus on dermal and intestinal wound healing. J Invest
Surg. 2005;18:71e79.
27. Loram LC, Themistocleous AC, Fick LG, Kamerman PR. The
time course of inflammatory cytokine secretion in a rat model
of postoperative pain does not coincide with the onset of
mechanical hyperalgesia. Can J Physiol Pharmacol. 2007;85:
613e620.
28. Yadav A, Saini V, Arora S. MCP-1: chemoattractant with a role
beyond immunity: a review. Clin Chim Acta. 2010;411:
1570e1579.
29. Mazzucchelli L, Loetscher P, Kappeler A, et al. Monocyte
chemoattractant protein-1 gene expression in prostatichyperplasia and prostate adenocarcinoma. Am J Pathol. 1996;
149:501e509.
30. McCormack G, Moriarty D, O’Donoghue DP, et al. Tissue cyto-
kine and chemokine expression in inflammatory bowel disease.
Inflamm Res. 2001;50:491e495.
31. Reinecker HC, Loh EY, Ringler DJ, et al. Monocyte-chemo-
attractant protein 1 gene expression in intestinal epithelial
cells and inflammatory bowel disease mucosa. Gastroenter-
ology. 1995;108:40e50.
32. Grimm MC, Elsbury SK, Pavli P, Doe WF. Enhanced expression
and production of monocyte chemoattractant protein-1 in in-
flammatory bowel disease mucosa. J Leukoc Biol. 1996;59:
804e812.
33. Alzoghaibi MA, Walsh SW, Willey A, Fowler III AA, Graham MF.
Linoleic acid, but not oleic acid, upregulates the production of
interleukin-8 by human intestinal smooth muscle cells isolated
from patients with Crohn’s disease. Clin Nutr. 2003;22:
529e535.
34. Margadant C, Sonnenberg A. Integrin-TGF-beta crosstalk in
fibrosis, cancer and wound healing. EMBO Rep. 2010;11:
97e105.
35. Faler BJ, Macsata RA, Plummer D, Mishra L, Sidawy AN.
Transforming growth factor-beta and wound healing. Perspect
Vasc Surg Endovasc Ther. 2006;18:55e62.
36. Buckmire MA, Parquet G, Greenway S, Rolandelli RH. Temporal
expression of TGF-beta1, EGF, and PDGF-BB in a model of
colonic wound healing. J Surg Res. 1998;80:52e57.
